SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Marijuana Stocks
CGC 1.255-2.7%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Savant who wrote (3465)3/25/2024 11:35:51 AM
From: Savant2 Recommendations

Recommended By
onepath
vitalremains

   of 3484
 
A recent FDA report makes the case that the U.S. Drug Enforcement Administration ( DEA) should move cannabis from the Schedule 1 to the Schedule 3 category of the Controlled Substances Act.

“The definition of a schedule 1 drug says it has no health benefits to it, and, so, obviously, there’s been plenty of research that has documented the multitudes of ways that cannabis can be helpful,” Dr. David Berger from Wholistic ReLeaf, a medical clinic in Florida, told Tampa news station WFTS-TV for a report on Thursday, March 21.

FDA Says Marijuana Serves Legitimate Medical Purpose, Calls for Drug to Be Reclassified to Risk Category Below Fentanyl (msn.com)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News